U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 313

1.
Combined mobilization and stimulation of tumor‐infiltrating dendritic cells and natural killer cells with Flt3 ligand and IL‐18 in vivo induces systemic antitumor immunity
Tetsuya Saito, Takuya Takayama, Tadashi Osaki, Shigenori Nagai, Toshihiro Suzuki, Marimo Sato, Hiroyuki Kuwano, Hideaki Tahara
Cancer Sci. 2008 Oct; 99(10): 2028–2036. Published online 2008 Oct 13. doi: 10.1111/j.1349-7006.2008.00907.x
PMCID:
PMC11158939
AbstractArticlePDF–595K
2.
High FLT3 expression increases immune‐cell infiltration in the tumor microenvironment and correlates with prolonged disease‐free survival in patients with non‐small cell lung cancer
Łukasz Kuncman, Magdalena Orzechowska, Tomasz Milecki, Jakub Kucharz, Jacek Fijuth
Mol Oncol. 2024 May; 18(5): 1316–1326. Published online 2024 Feb 7. doi: 10.1002/1878-0261.13597
PMCID:
PMC11076988
AbstractArticlePDF–2.7M
3.
Prevalence of FMS-like tyrosine kinase 3/internal tandem duplication (FLT3/ITD+) in de novo acute myeloid leukemia patients categorized according to cytogenetic risk
Everson Augusto Krum, Mihoko Yamamoto, Maria de Lourdes Lopes Ferrari Chauffaille
Sao Paulo Med J. 2009; 127(1): 23–27. Published online 2009 May 11. doi: 10.1590/S1516-31802009000100006
PMCID:
PMC10969321
AbstractArticlePDF–149K
4.
Leukemic mutation FLT3-ITD is retained in dendritic cells and disrupts their homeostasis leading to expanded Th17 frequency
Patrick A. Flynn, Mark D. Long, Yoko Kosaka, Nicola Long, Jessica S. Mulkey, Jesse L. Coy, Anupriya Agarwal, Evan F. Lind
Front Immunol. 2024; 15: 1297338. Published online 2024 Mar 1. doi: 10.3389/fimmu.2024.1297338
PMCID:
PMC10943691
AbstractArticlePDF–6.1M
5.
Characterisation of FLT3 alterations in childhood acute lymphoblastic leukaemia
Angela Gutierrez-Camino, Chantal Richer, Manon Ouimet, Claire Fuchs, Sylvie Langlois, Fida Khater, Maxime Caron, Patrick Beaulieu, Pascal St-Onge, Alain R. Bataille, Daniel Sinnett
Br J Cancer. 2024 Feb 10; 130(2): 317–326. Published online 2023 Dec 4. doi: 10.1038/s41416-023-02511-8
PMCID:
PMC10803556
AbstractArticlePDF–1.1M
6.
A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
Eirini Giannakopoulou, Madeleine Lehander, Stina Virding Culleton, Weiwen Yang, Yingqian Li, Terhi Karpanen, Tetsuichi Yoshizato, Even H. Rustad, Morten Milek Nielsen, Ravi Chand Bollineni, Trung T. Tran, Marina Delic-Sarac, Thea Johanne Gjerdingen, Karolos Douvlataniotis, Maarja Laos, Muhammad Ali, Amy Hillen, Stefania Mazzi, Desmond Wai Loon Chin, Adi Mehta, Jeppe Sejerø Holm, Amalie Kai Bentzen, Marie Bill, Marieke Griffioen, Tobias Gedde-Dahl, Sören Lehmann, Sten Eirik W. Jacobsen, Petter S. Woll, Johanna Olweus
Nat Cancer. 2023; 4(10): 1474–1490. Published online 2023 Oct 2. doi: 10.1038/s43018-023-00642-8
PMCID:
PMC10597840
AbstractArticlePDF–20M
7.
Targeting conditioned media dependencies and FLT-3 in chronic lymphocytic leukemia
Salma Parvin, Aditi Aryal, Shanye Yin, Geoffrey G. Fell, Matthew S. Davids, Catherine J. Wu, Anthony Letai
Blood Adv. 2023 Oct 10; 7(19): 5877–5889. Published online 2023 Jul 20. doi: 10.1182/bloodadvances.2022008207
PMCID:
PMC10558618
AbstractArticlePDF–1.2M
8.
Insight and Recommendations for Fragile X-Premutation-Associated Conditions from the Fifth International Conference on FMR1 Premutation
Flora Tassone, Dragana Protic, Emily Graves Allen, Alison D. Archibald, Anna Baud, Ted W. Brown, Dejan B. Budimirovic, Jonathan Cohen, Brett Dufour, Rachel Eiges, Nicola Elvassore, Lidia V. Gabis, Samantha J. Grudzien, Deborah A. Hall, David Hessl, Abigail Hogan, Jessica Ezzell Hunter, Peng Jin, Poonnada Jiraanont, Jessica Klusek, R. Frank Kooy, Claudine M. Kraan, Cecilia Laterza, Andrea Lee, Karen Lipworth, Molly Losh, Danuta Loesch, Reymundo Lozano, Marsha R. Mailick, Apostolos Manolopoulos, Veronica Martinez-Cerdeno, Yingratana McLennan, Robert M. Miller, Federica Alice Maria Montanaro, Matthew W. Mosconi, Sarah Nelson Potter, Melissa Raspa, Susan M. Rivera, Katharine Shelly, Peter K. Todd, Katarzyna Tutak, Jun Yi Wang, Anne Wheeler, Tri Indah Winarni, Marwa Zafarullah, Randi J. Hagerman
Cells. 2023 Sep; 12(18): 2330. Published online 2023 Sep 21. doi: 10.3390/cells12182330
PMCID:
PMC10529056
AbstractArticlePDF–4.4M
9.
NUP98::Nsd1 and FLT3-ITD collaborate to generate acute myeloid leukemia
Toshihiro Matsukawa, Mianmian Yin, Nupur Nigam, Vijay Negi, Li Li, Donald Small, Yuelin J. Zhu, Robert L. Walker, Paul S. Meltzer, Peter D. Aplan
Leukemia. 2023; 37(7): 1545–1548. Published online 2023 May 5. doi: 10.1038/s41375-023-01913-0
PMCID:
PMC10317830
ArticlePDF–2.2M
10.
Concomitant targeting of FLT3 and BTK overcomes FLT3 inhibitor resistance in acute myeloid leukemia through the inhibition of autophagy
Weiguo Zhang, Guopan Yu, Hongying Zhang, Mahesh Basyal, Charlie Ly, Bin Yuan, Vivian Ruvolo, Sujan Piya, Seemana Bhattacharya, Qi Zhang, Gautam Borthakur, Venkata L. Battula, Marina Konopleva, William G. Rice, Michael Andreeff
Haematologica. 2023 Jun 1; 108(6): 1500–1514. Published online 2022 Oct 13. doi: 10.3324/haematol.2022.280884
PMCID:
PMC10230429
AbstractArticlePDF–3.0M
11.
Disrupting autophagy in FLT3-mutant acute myeloid leukemia
Steven Grant
Haematologica. 2023 Jun 1; 108(6): 1458–1460. Published online 2022 Nov 17. doi: 10.3324/haematol.2022.282054
PMCID:
PMC10230404
ArticlePDF–1.2M
12.
FLT3ITD drives context-specific changes in cell identity and variable interferon dependence during AML initiation
Yanan Li, Wei Yang, Riddhi M. Patel, Emily B. Casey, Elisabeth Denby, Jonny Mendoza-Castrejon, Priscilla Rodriguez-Lopez, Jeffrey A. Magee
Blood. 2023 Mar 23; 141(12): 1442–1456. Published online 2022 Nov 21. doi: 10.1182/blood.2022016889
PMCID:
PMC10082380
AbstractArticle
13.
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant
Laura W. Dillon, Gege Gui, Kristin M. Page, Niveditha Ravindra, Zoë C. Wong, Georgia Andrew, Devdeep Mukherjee, Scott L. Zeger, Firas El Chaer, Stephen Spellman, Alan Howard, Karen Chen, Jeffery Auletta, Steven M. Devine, Antonio Martin Jimenez Jimenez, Marcos J. G. De Lima, Mark R. Litzow, Partow Kebriaei, Wael Saber, Daniel J. Weisdorf, Christopher S. Hourigan
JAMA. 2023 Mar 7; 329(9): 745–755. Published online 2023 Mar 7. doi: 10.1001/jama.2023.1363
PMCID:
PMC9993183
AbstractArticle
14.
FLT3 functional low-frequency variant rs76428106-C is associated with susceptibility to systemic sclerosis
Javier Martínez-López, Martin Kerick, Lourdes Ortiz-Fernández, Marialbert Acosta-Herrera, Ana Márquez, Javier Martín
Rheumatology (Oxford) 2023 Feb; 62(SI): SI138–SI142. Published online 2022 Jul 25. doi: 10.1093/rheumatology/keac406
PMCID:
PMC9910569
AbstractArticlePDF–240K
15.
Novel investigational approaches for high-risk genetic subsets of AML: TP53, KMT2A, FLT3
Kieran D. Sahasrabudhe, Alice S. Mims
Hematology Am Soc Hematol Educ Program. 2022 Dec 9; 2022(1): 15-22. Published online 2022 Dec 9. doi: 10.1182/hematology.2022000325
PMCID:
PMC9820850
AbstractArticlePDF–398K
16.
Association between FLT3-ITD and additional chromosomal abnormalities in the prognosis of acute promyelocytic leukemia
Minh Phuong Vu, Cuc Nhung Nguyen, Hoang Vu, Tuyet Mai Nguyen, Tuan Tung Nguyen, Phuong Thao Pham
J Int Med Res. 2022 Dec; 50(12): 03000605221138490. Published online 2022 Dec 20. doi: 10.1177/03000605221138490
PMCID:
PMC9791292
AbstractArticlePDF–454K
17.
Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia
Christopher E. Jensen, Nathan D. Montgomery, Jonathan Galeotti, Matthew C. Foster, Joshua F. Zeidner
J Cell Mol Med. 2022 Dec; 26(24): 6079–6082. Published online 2022 Nov 28. doi: 10.1111/jcmm.17608
PMCID:
PMC9753433
ArticlePDF–236K
18.
FLT3 Gene Mutations in Acute Myeloid Leukemia Patients in Northeast Thailand
Nang Ei Ei Aung, Supawadee Yamsri, Nattiya Teawtrakul, Piyawan Kamsaen, Supan Fucharoen
Med Sci Monit Basic Res. 2022; 28: e937446-1–e937446-11. Published online 2022 Nov 24. doi: 10.12659/MSMBR.937446
PMCID:
PMC9707044
AbstractArticlePDF–1.2M
19.
Lack of FLT3-ITD in Tunisian childhood acute lymphoblastic leukemia
Rim Frikha, Nawel Abdellaoui, Olfa Kassar, Tarek Rebai
Afr Health Sci. 2022 Jun; 22(2): 318–322. doi: 10.4314/ahs.v22i2.35
PMCID:
PMC9652637
AbstractArticlePDF–286K
20.
FBP1-Altered Carbohydrate Metabolism Reduces Leukemic Viability through Activating P53 and Modulating the Mitochondrial Quality Control System In Vitro
Yi Xu, Lily Tran, Janet Tang, Vinh Nguyen, Elisabeth Sewell, Jeffrey Xiao, Christopher Hino, Samiksha Wasnik, Olivia L. Francis-Boyle, Ke K. Zhang, Linglin Xie, Jiang F. Zhong, David J. Baylink, Chien-Shing Chen, Mark E. Reeves, Huynh Cao
Int J Mol Sci. 2022 Oct; 23(19): 11387. Published online 2022 Sep 27. doi: 10.3390/ijms231911387
PMCID:
PMC9570078
AbstractArticlePDF–3.1M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center